|
1
|
Ye JZ, Wang YY, Bai T, Chen J, Xiang BD,
Wu FX and Li LQ: Surgical resection for hepatocellular carcinoma
with portal vein tumor thrombus in the Asia-Pacific region beyond
the Barcelona Clinic Liver Cancer treatment algorithms: A review
and update. Oncotarget. 8:93258–93278. 2017.PubMed/NCBI
|
|
2
|
Orcutt ST and Anaya DA: Liver resection
and surgical strategies for management of primary liver cancer.
Cancer Control. 25:10732748177446212018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ren FH, Yang H, He RQ, Lu JN, Lin XG,
Liang HW, Dang YW, Feng ZB, Chen G and Luo DZ: Analysis of
microarrays of miR-34a and its identification of prospective target
gene signature in hepatocellular carcinoma. BMC Cancer. 18:122018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geng M, Xin X, Bi LQ, Zhou LT and Liu XH:
Molecular mechanism of hepatitis B virus X protein function in
hepatocarcinogenesis. World J Gastroenterol. 21:10732–10738. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Novikova MV, Khromova NV and Kopnin PB:
Components of the hepatocellular carcinoma microenvironment and
their role in tumor progression. Biochemistry (Mosc). 82:861–873.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoo S, Wang W, Wang Q, Fiel MI, Lee E,
Hiotis SP and Zhu J: A pilot systematic genomic comparison of
recurrence risks of hepatitis B virus-associated hepatocellular
carcinoma with low- and high-degree liver fibrosis. BMC Med.
15:2142017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang G, Fang X, Han M, Wang X and Huang Q:
MicroRNA-493-5p promotes apoptosis and suppresses proliferation and
invasion in liver cancer cells by targeting VAMP2. Int J Mol Med.
41:1740–1748. 2018.PubMed/NCBI
|
|
8
|
Lin H, Ewing LE, Koturbash I, Gurley BJ
and Miousse IR: MicroRNAs as biomarkers for liver injury: Current
knowledge, challenges and future prospects. Food Chem Toxicol.
110:229–239. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loosen SH, Schueller F, Trautwein C, Roy S
and Roderburg C: Role of circulating microRNAs in liver diseases.
World J Hepatol. 9:586–594. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashmawy AM, Elgeshy KM, Abdel Salam ET,
Ghareeb M, Kobaisi MH, Amin HAA, Sharawy SK and Abdel Wahab AHA:
Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway
in hepatocellular carcinoma patients. Arab J Gastroenterol.
18:144–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singaravelu R, Quan C, Powdrill MH, Shaw
TA, Srinivasan P, Lyn RK, Alonzi RC, Jones DM, Filip R, Russell RS
and Pezacki JP: MicroRNA-7 mediates cross-talk between metabolic
signaling pathways in the liver. Sci Rep. 8:3612018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou SJ, Liu FY, Zhang AH, Liang HF, Wang
Y, Ma R, Jiang YH and Sun NF: MicroRNA-199b-5p attenuates
TGF-β1-induced epithelial-mesenchymal transition in hepatocellular
carcinoma. Br J Cancer. 117:233–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu D, Hu Y, Xu W, Yu H, Yang N, Ni S and
Fu R: miR-203 inhibits the expression of collagen-related genes and
the proliferation of hepatic stellate cells through a
SMAD3-dependent mechanism. Mol Med Rep. 16:1248–1254. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Riazalhosseini B, Mohamed R, Apalasamy YD,
Langmia IM and Mohamed Z: Circulating microRNA as a marker for
predicting liver disease progression in patients with chronic
hepatitis B. Rev Soc Bras Med Trop. 50:161–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S, Wang JQ and Lv XW: Exosomal miRNAs
as biomarkers in the diagnosis of liver disease. Biomark Med.
11:491–501. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slaby O, Laga R and Sedlacek O:
Therapeutic targeting of non-coding RNAs in cancer. Biochem J.
474:4219–4251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vettukattil JJ: Is the hepatic factor a
miRNA that maintains the integrity of pulmonary microvasculature by
inhibiting the vascular endothelial growth factor? Curr Cardiol
Rev. 13:244–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YY, Wu ZY, Wang GC, Liu K, Niu XB, Gu
S and Meng JS: LINC00312 inhibits the migration and invasion of
bladder cancer cells by targeting miR-197-3p. Tumor Biol.
37:14553–14563. 2016. View Article : Google Scholar
|
|
19
|
Liu K, Huang W, Yan DQ, Luo Q and Min X:
Overexpression of long intergenic noncoding RNA LINC00312 inhibits
the invasion and migration of thyroid cancer cells by
down-regulating microRNA-197-3p. Biosci Rep. 37(pii):
BSR201701092017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pirisi M, Leutner M, Pinato DJ, Avellini
C, Carsana L, Toniutto P, Fabris C and Boldorini R: Reliability and
reproducibility of the edmondson grading of hepatocellular
carcinoma using paired core biopsy and surgical resection
specimens. Arch Pathol Lab Med. 134:1818–1822. 2010.PubMed/NCBI
|
|
21
|
Chansky K, Sculier JP, Crowley JJ, Giroux
D, Van Meerbeeck J and Goldstraw P: International Staging Committee
and Participating Institutions: The international association for
the study of lung cancer staging project: Prognostic factors and
pathologic TNM stage in surgically managed non-small cell lung
cancer. J Thorac Oncol. 4:792–801. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG,
Ma L, Liu X and Li LQ: Comparison of long-term survival of patients
with BCLC stage B hepatocellular carcinoma after liver resection or
transarterial chemoembolization. PLoS One. 8:e681932013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang RY, Chen L, Chen HY, Hu L, Li L, Sun
HY, Jiang F, Zhao J, Liu GM, Tang J, et al: MUC15 inhibits
dimerization of EGFR and PI3K-AKT signaling and is associated with
aggressive hepatocellular carcinomas in patients. Gastroenterology.
145:1436–1448, e1-e12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shiraki K, Takase K, Tameda Y, Hamada M,
Kosaka Y and Nakano T: A clinical study of lectin-reactive
alpha-fetoprotein as an early indicator of hepatocellular carcinoma
in the follow-up of cirrhotic patients. Hepatology. 22:802–807.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li D, Mallory T and Satomura S: AFP-L3: A
new generation of tumor marker for hepatocellular carcinoma. Clin
Chim Acta. 313:15–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv X, Li J and Yang B: Clinical effects of
miR-101 on prognosis of hepatocellular carcinoma and carcinogenic
mechanism of anti-miR-101. Oncol Rep. 36:2184–2192. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murakami Y, Kubo S, Tamori A, Itami S,
Kawamura E, Iwaisako K, Ikeda K, Kawada N, Ochiya T and Taguchi YH:
Comprehensive analysis of transcriptome and metabolome analysis in
intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci
Rep. 5:162942015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qadir MI and Rizvi SZ: miRNA in
hepatocellular carcinoma: Pathogenesis and therapeutic approaches.
Crit Rev Eukaryot Gene Expr. 27:355–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Almas I, Afzal S, Idrees M, Ashraf MU,
Amin I, Shahid M, Zahid K and Zahid S: Role of circulatory
microRNAs in the pathogenesis of hepatitis C virus. Virusdisease.
28:360–367. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Daniel R, Wu Q, Williams V, Clark G,
Guruli G and Zehner Z: A panel of MicroRNAs as diagnostic
biomarkers for the identification of prostate cancer. Int J Mol
Sci. 18(pii): E12812017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tayob N, Richardson P, White DL, Yu X,
Davila JA, Kanwal F, Feng Z and El-Serag HB: Evaluating screening
approaches for hepatocellular carcinoma in a cohort of HCV related
cirrhosis patients from the Veteran's Affairs Health Care System.
BMC Med Res Methodol. 18:12018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ricco G, Cavallone D, Cosma C, Caviglia
GP, Oliveri F, Biasiolo A, Abate ML, Plebani M, Smedile A, Bonino
F, et al: Impact of etiology of chronic liver disease on
hepatocellular carcinoma biomarkers. Cancer Biomark. 21:603–612.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luma HN, Eloumou SAFB, Okalla C,
Donfack-Sontsa O, Koumitana R, Malongue A, Nko'Ayissi GB and Noah
DN: Prevalence and characteristics of hepatitis delta virus
infection in a tertiary hospital setting in cameroon. J Clin Exp
Hepatol. 7:334–339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu WF, Fei YM, Zhou JK, Shen HJ, Chen XF,
Lv QQ and Ding YY: Significance of serum golgi protein 73 (GP73),
alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein
(AFP-L3) expresssion in primary hepatic carcinoma. Zhonghua Shi Yan
He Lin Chuang Bing Du Xue Za Zhi. 25:286–288. 2011.(In Chinese).
PubMed/NCBI
|
|
36
|
Kamiyama T, Takahashi M, Nakagawa T,
Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki
M, Matsushita M, et al: AFP mRNA detected in bone marrow by
real-time quantitative RT-PCR analysis predicts survival and
recurrence after curative hepatectomy for hepatocellular carcinoma.
Ann Surg. 244:451–463. 2006.PubMed/NCBI
|
|
37
|
Hartmann JT, Rick O, Oechsle K, Kuczyk M,
Gauler T, Schöffski P, Schleicher J, Mayer F, Teichmann R, Kanz L
and Bokemeyer C: Role of postchemotherapy surgery in the management
of patients with liver metastases from germ cell tumors. Ann Surg.
242:260–266. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang GT, Lee PH, Tsang YM, Lai MY, Yang
PM, Hu RH, Chen PJ, Kao JH, Sheu JC, Lee CZ and Chen DS:
Percutaneous ethanol injection versus surgical resection for the
treatment of small hepatocellular carcinoma: A prospective study.
Ann Surg. 242:36–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Y, Yang Z, Du F, Yang Q, Hou J, Yan X,
Geng Y, Zhao Y and Wang H: Molecular mechanisms of pathogenesis in
hepatocellular carcinoma revealed by RNA-sequencing. Mol Med Rep.
16:6674–6682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Morimoto A, Kannari M, Tsuchida Y, Sasaki
S, Saito C, Matsuta T, Maeda T, Akiyama M, Nakamura T, Sakaguchi M,
et al: An HNF4α-microRNA-194/192 signaling axis maintains hepatic
cell function. J Biol Chem. 292:10574–10585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Denisenko ON, O'Neill B, Ostrowski J, Van
Seuningen I and Bomsztyk K: Zik1, a transcriptional repressor that
interacts with the heterogeneous nuclear ribonucleoprotein particle
K protein. J Biol Chem. 271:27701–27706. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mihara M, Yoshida Y, Tsukamoto T, Inada K,
Nakanishi Y, Yagi Y, Imai K, Sugimura T, Tatematsu M and Ushijima
T: Methylation of multiple genes in gastric glands with intestinal
metaplasia: A disorder with polyclonal origins. Am J Pathol.
169:1643–1651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao Q, Kun D, Hong B, Deng X, Guo S, Tang
X, Yang Y, Gong K, Li Q, Ye L, et al: Identification of novel
proteins interacting with vascular endothelial growth inhibitor 174
in renal cell carcinoma. Anticancer Res. 37:4379–4388.
2017.PubMed/NCBI
|
|
45
|
Liu P, Jiang W, Zhao J and Zhang H:
Integrated analysis of genome-wide gene expression and DNA
methylation microarray of diffuse large B-cell lymphoma with TET
mutations. Mol Med Rep. 16:3777–3782. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Oka D, Yamashita S, Tomioka T, Nakanishi
Y, Kato H, Kaminishi M and Ushijima T: The presence of aberrant DNA
methylation in noncancerous esophageal mucosae in association with
smoking history: A target for risk diagnosis and prevention of
esophageal cancers. Cancer. 115:3412–3426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim ST, Sohn I, Do IG, Jang J, Kim SH,
Jung IH, Park JO, Park YS, Talasaz A, Lee J and Kim HC:
Transcriptome analysis of CD133-positive stem cells and prognostic
value of survivin in colorectal cancer. Cancer Genomics Proteomics.
11:259–266. 2014.PubMed/NCBI
|
|
48
|
Borinstein SC, Conerly M, Dzieciatkowski
S, Biswas S, Washington MK, Trobridge P, Henikoff S and Grady WM:
Aberrant DNA methylation occurs in colon neoplasms arising in the
azoxymethane colon cancer model. Mol Carcinog. 49:94–103.
2010.PubMed/NCBI
|
